Why HIV & TB Research ?

Why HIV & TB Research ?

There has been progress in reducing TB cases and deaths in the past decade and mortality and incidence rates are decreasing globally.

Read More

Engaging Communities

Engaging Communities

The CAB (Community Advisory Board) engages with local communities and is teaching them about Tuberculosis and its consequences.

Read More

News

News

Know more about the world of research and how we work together with others to win the fight against TB.

Read More

About TASK

TASK Applied Science performs clinical trials in tuberculosis (TB) in Cape Town, South Africa. The high incidence of tuberculosis in our region illustrates the great need for better diagnostic tests and more effective treatments for TB. TASK can provide assistance to efficiently conduct studies for diagnosis, treatment or prevention of Tuberculosis.

TASK Applied Science was founded in 2005 by Prof. Andreas Diacon to accelerate the development and evaluation of novel anti-tuberculosis drugs. TASK has completed several important projects in the last 10 years and contributed significantly to moving forward of the entire scientific field. TASK mainly collaborates with international NGOs, government funded consortia, academic centers and pharmaceutical companies on various drug development projects.

TASK now employs over 170 staff members and has invested in laboratory capacity and in a network of clinical sites in underprivileged areas in Cape Town.